Skip to main content
Erschienen in: Acta Diabetologica 12/2020

01.08.2020 | Original Article

Adherence to a follow-up program after gestational diabetes

verfasst von: Maria Grazia Dalfrà, Silvia Burlina, Gloria Giovanna Del Vescovo, Francesca Anti, Annunziata Lapolla

Erschienen in: Acta Diabetologica | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this study was to examine attendance for early postpartum follow-up among women with gestational diabetes mellitus (GDM), and to identify factors that influenced their likelihood of attending.

Methods

One thousand eight hundred and nineteen women with GDM were retrospectively analyzed. During pregnancy, the following data were collected: age, family history of diabetes, ethnicity, prepregnancy BMI, fasting plasma glucose, glycated hemoglobin, gestational week of GDM diagnosis, timing and mode of delivery, newborn’s birth weight and length. Glycemia and insulinemia during OGTT, lipid profile and postpartum BMI were assessed at follow-up. Based on the OGTT, women were classified as having normal glucose tolerance (NGT) or abnormal glucose tolerance (AGT), which included impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG + IGT, and DM2. Factors predicting postpartum attendance for follow-up and onset of AGT were considered.

Results

Of the 889 (48.9%) who attended the scheduled postpartum OGTT, 741 (83.4%) had NGT, while 148 (16.6%) had AGT (IFG 6.7%, IGT 7.7%, IFG + IGT 0.8%, DM2 1.5%). The predictors of adherence to follow-up were: not belonging to an immigrant group; family history of DM2; and insulin therapy in pregnancy. The same factors were also predictive of AGT. Our data suggest a role of ethnicity in both attendance for postpartum follow-up and its outcome.

Conclusion

Despite efforts to provide care for women with GDM, postpartum screening rates are still low among Italian women, and especially among immigrants. Hence, the need to improve these patients’ awareness of the severe risk of developing diabetes after pregnancy, concentrating efforts especially on women belonging to the most at risk ethnic groups.
Literatur
1.
Zurück zum Zitat Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677):1773–1779CrossRefPubMed Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677):1773–1779CrossRefPubMed
2.
Zurück zum Zitat Kwak SH, Choi SH, Jung HS et al (2013) Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab 8(4):E744–E752CrossRef Kwak SH, Choi SH, Jung HS et al (2013) Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab 8(4):E744–E752CrossRef
3.
Zurück zum Zitat Ferrara A, Peng T, Kim C (2009) Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 32(2):269–274CrossRefPubMedPubMedCentral Ferrara A, Peng T, Kim C (2009) Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 32(2):269–274CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868CrossRefPubMed Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10):1862–1868CrossRefPubMed
5.
Zurück zum Zitat Dabelea D, Snell-Bergeon JK, Hartsfield CL et al (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and birth cohort: Kaiser permanent of Colorado GDM screening program. Diabetes Care 28:579–584CrossRefPubMed Dabelea D, Snell-Bergeon JK, Hartsfield CL et al (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and birth cohort: Kaiser permanent of Colorado GDM screening program. Diabetes Care 28:579–584CrossRefPubMed
6.
Zurück zum Zitat Fujimoto W, Samoa R, Wotring A (2013) Gestational diabetes in high-risk population. Clin Diabetes 31:90–94CrossRef Fujimoto W, Samoa R, Wotring A (2013) Gestational diabetes in high-risk population. Clin Diabetes 31:90–94CrossRef
7.
Zurück zum Zitat Noctor E, Crowe C, Carmody LA et al (2015) Prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 52(1):153–156CrossRefPubMed Noctor E, Crowe C, Carmody LA et al (2015) Prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 52(1):153–156CrossRefPubMed
8.
Zurück zum Zitat Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23(2):135–140CrossRefPubMed Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23(2):135–140CrossRefPubMed
10.
Zurück zum Zitat Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93(12):4774–4779CrossRefPubMedPubMedCentral Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93(12):4774–4779CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat ACOG Practice bullettin – Obstetrics (2013) ACOG Practice Bullettin No 137: gestational diabetes mellitus. Obstet Gynecol 122:406–416CrossRef ACOG Practice bullettin – Obstetrics (2013) ACOG Practice Bullettin No 137: gestational diabetes mellitus. Obstet Gynecol 122:406–416CrossRef
12.
Zurück zum Zitat American Diabetes Association (2020) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 43(Suppl 1):S14–S31CrossRef American Diabetes Association (2020) Standard of medical care in diabetes. Gestational diabetes mellitus. Diabetes Care 43(Suppl 1):S14–S31CrossRef
13.
Zurück zum Zitat Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211CrossRefPubMed Hod M, Kapur A, Sacks DA et al (2015) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet 131(Suppl 3):S173–S211CrossRefPubMed
14.
Zurück zum Zitat NICE Guideliness 2015. Diabetes in pregnancy NICE Guideliness 2015. Diabetes in pregnancy
15.
Zurück zum Zitat Pastore I, Chiefari E, Vero R et al (2018) Postpartum glucose intolerance: an updated overview. Endocrine 59:481–494CrossRefPubMed Pastore I, Chiefari E, Vero R et al (2018) Postpartum glucose intolerance: an updated overview. Endocrine 59:481–494CrossRefPubMed
16.
Zurück zum Zitat Hamel MS, Werner EF (2017) Interventions to improve rate of diabetes testing postpartum in women with gestational diabetes mellitus. Curr Diab Rep 17:1–7CrossRef Hamel MS, Werner EF (2017) Interventions to improve rate of diabetes testing postpartum in women with gestational diabetes mellitus. Curr Diab Rep 17:1–7CrossRef
17.
Zurück zum Zitat International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentral International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682CrossRefPubMedCentral
18.
Zurück zum Zitat Ministero della Salute. Sistema Nazionale per le Linee Guida Gravidanza Fisiologica 2014 Ministero della Salute. Sistema Nazionale per le Linee Guida Gravidanza Fisiologica 2014
19.
Zurück zum Zitat American Diabetes Association (2020) Classification and diagnosis of diabetes. Diabetes Care 43(Suppl 1):S25–S27 American Diabetes Association (2020) Classification and diagnosis of diabetes. Diabetes Care 43(Suppl 1):S25–S27
20.
Zurück zum Zitat Huggett AS, Nixon DA (1957) Use of glucoseoxidase, peroxidase, and O-dianisidine in determination of blood and urinaryglucose. Lancet 273(6991):368–370CrossRefPubMed Huggett AS, Nixon DA (1957) Use of glucoseoxidase, peroxidase, and O-dianisidine in determination of blood and urinaryglucose. Lancet 273(6991):368–370CrossRefPubMed
21.
Zurück zum Zitat Cosma C, Padoan PA, Clerico A et al (2019) C-peptide and insulin assays with the Mindray CL-2000i: precision and comparability with differen methods. Clin Chim Acta 495:210–214CrossRefPubMed Cosma C, Padoan PA, Clerico A et al (2019) C-peptide and insulin assays with the Mindray CL-2000i: precision and comparability with differen methods. Clin Chim Acta 495:210–214CrossRefPubMed
22.
Zurück zum Zitat Mosca A, Paleari R, Dalfrà MG et al (2006) Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 52:1138–1143CrossRefPubMed Mosca A, Paleari R, Dalfrà MG et al (2006) Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 52:1138–1143CrossRefPubMed
23.
Zurück zum Zitat Dastych M, Wiewiofka O, Benovska M (2014) Ethamsylate (Dicynone) interference in determination of serum creatinine, uric acid, triglycerides and cholesterol in assays involving the Trinder reaction: in vivo and in vitro. Clin Lab 60:1373–1376CrossRefPubMed Dastych M, Wiewiofka O, Benovska M (2014) Ethamsylate (Dicynone) interference in determination of serum creatinine, uric acid, triglycerides and cholesterol in assays involving the Trinder reaction: in vivo and in vitro. Clin Lab 60:1373–1376CrossRefPubMed
24.
Zurück zum Zitat Lawrence JM, Black MH, Hsu JW et al (2010) Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 33(3):569–576CrossRefPubMed Lawrence JM, Black MH, Hsu JW et al (2010) Prevalence and timing of postpartum glucose testing and sustained glucose dysregulation after gestational diabetes mellitus. Diabetes Care 33(3):569–576CrossRefPubMed
25.
Zurück zum Zitat Russell MA, Phipps MG, Olson CL et al (2006) Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 108(6):1456–1462CrossRefPubMed Russell MA, Phipps MG, Olson CL et al (2006) Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 108(6):1456–1462CrossRefPubMed
26.
Zurück zum Zitat Capula C, Chiefari E, Vero A et al (2014) Prevalence and predictors of postpartum glucose intolerance in italian women with gestational diabetes mellitus. Diabetes Res Clin Pract 105:223–230CrossRefPubMed Capula C, Chiefari E, Vero A et al (2014) Prevalence and predictors of postpartum glucose intolerance in italian women with gestational diabetes mellitus. Diabetes Res Clin Pract 105:223–230CrossRefPubMed
27.
Zurück zum Zitat Hunt KJ, Conway DL (2008) Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 198(4):404.e1–404.e6CrossRef Hunt KJ, Conway DL (2008) Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 198(4):404.e1–404.e6CrossRef
28.
Zurück zum Zitat Waters TP, Kim SY, Sharma AJ et al (2020) Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period. Diabetologia 63:385–394CrossRefPubMed Waters TP, Kim SY, Sharma AJ et al (2020) Longitudinal changes in glucose metabolism in women with gestational diabetes, from late pregnancy to the postpartum period. Diabetologia 63:385–394CrossRefPubMed
29.
Zurück zum Zitat Blatt AJ, Nakamoto JM, Kaufman HW (2011) Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol 117:61–68CrossRefPubMed Blatt AJ, Nakamoto JM, Kaufman HW (2011) Gaps in diabetes screening during pregnancy and postpartum. Obstet Gynecol 117:61–68CrossRefPubMed
31.
Zurück zum Zitat Dalfrà MG, Ragazzi E, Masin M et al (2001) Pregnancy outcome in immigrant women with gestational diabetes mellitus. Gynecol Endocrinol 27(6):379–383CrossRef Dalfrà MG, Ragazzi E, Masin M et al (2001) Pregnancy outcome in immigrant women with gestational diabetes mellitus. Gynecol Endocrinol 27(6):379–383CrossRef
33.
Zurück zum Zitat Liu H, Zhang C, Zhang S et al (2014) Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes. Obesity 22(6):1560–1567CrossRefPubMed Liu H, Zhang C, Zhang S et al (2014) Prepregnancy body mass index and weight change on postpartum diabetes risk among gestational diabetes. Obesity 22(6):1560–1567CrossRefPubMed
34.
Zurück zum Zitat Burlina S, Dalfrà MG, Lapolla A (2018) Clinical and biochemical approach to predicting post-pregnancy metabolic decompensation. Diabetes Res Clin Pract 145:178–183CrossRefPubMed Burlina S, Dalfrà MG, Lapolla A (2018) Clinical and biochemical approach to predicting post-pregnancy metabolic decompensation. Diabetes Res Clin Pract 145:178–183CrossRefPubMed
35.
Zurück zum Zitat Kim SH, Kim MY, Yang JH et al (2011) Nutritional risk factors of early development of postpartum prediabetes and diabetes in women with gestational diabetes mellitus. Nutrition 27(7–8):782–788CrossRefPubMed Kim SH, Kim MY, Yang JH et al (2011) Nutritional risk factors of early development of postpartum prediabetes and diabetes in women with gestational diabetes mellitus. Nutrition 27(7–8):782–788CrossRefPubMed
36.
Zurück zum Zitat Benhalima K, Leuridan L, Calewaert P et al (2014) Glucose intolerance after a recent history of gestational diabetes. Int J Endocrinol. ID:727652 Benhalima K, Leuridan L, Calewaert P et al (2014) Glucose intolerance after a recent history of gestational diabetes. Int J Endocrinol. ID:727652
37.
Zurück zum Zitat Dalfra MG, Lapolla A, Masin M et al (2001) Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab 27(6):675–680PubMed Dalfra MG, Lapolla A, Masin M et al (2001) Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab 27(6):675–680PubMed
38.
Zurück zum Zitat Kampmann U, Knorr S, Fuglsang J et al (2019) Determinants of maternal insulin resistance during pregnancy: an updated over review. J Diabetes Research ID 5320156 Kampmann U, Knorr S, Fuglsang J et al (2019) Determinants of maternal insulin resistance during pregnancy: an updated over review. J Diabetes Research ID 5320156
39.
Zurück zum Zitat Lapolla A, Dalfra MG, Mello G, Parretti E, Cioni R, Marzari C et al (2008) Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab 93(3):876–880CrossRefPubMed Lapolla A, Dalfra MG, Mello G, Parretti E, Cioni R, Marzari C et al (2008) Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J Clin Endocrinol Metab 93(3):876–880CrossRefPubMed
40.
Zurück zum Zitat Ley SH, Chavarro JE, Li M et al (2020) Lactation duration and long-term risk for incident type 2 diabetes in women with a history of gestational diabetes mellitus. Diabetes Care 43:793–798CrossRefPubMedPubMedCentral Ley SH, Chavarro JE, Li M et al (2020) Lactation duration and long-term risk for incident type 2 diabetes in women with a history of gestational diabetes mellitus. Diabetes Care 43:793–798CrossRefPubMedPubMedCentral
Metadaten
Titel
Adherence to a follow-up program after gestational diabetes
verfasst von
Maria Grazia Dalfrà
Silvia Burlina
Gloria Giovanna Del Vescovo
Francesca Anti
Annunziata Lapolla
Publikationsdatum
01.08.2020
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 12/2020
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-020-01564-y

Weitere Artikel der Ausgabe 12/2020

Acta Diabetologica 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.